MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
Myocardial Infarction, Heart Failure, Systolic, Heart Valve Diseases
About this trial
This is an interventional treatment trial for Myocardial Infarction focused on measuring cardiac rehabilitation, telehealth
Eligibility Criteria
Inclusion Criteria: Age 18 or older Eligible for cardiac rehabilitation Diagnosis within 1 year prior to consent Myocardial infarction Percutaneous coronary intervention Coronary artery bypass Heart valve repair or replacement Heart transplant Chronic stable angina, or Chronic systolic heart failure (ejection fraction ≤ 35%) Willing to be randomized to in-person or telehealth cardiac rehabilitation Able to communicate in English or Spanish Exclusion Criteria: Unstable arrhythmias which may make unmonitored exercise unsafe (e.g., history of ventricular tachycardia not on medical therapy and without an implantable cardioverter defibrillator) Unsafe for patient to participate in the opinion of the investigator Hospice Unable to consent for self
Sites / Locations
- University of California, San Francisco
- Johns Hopkins University Medical Center
- University of Michigan
- University of Pittsburgh Medical Center
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
In-person cardiac rehabilitation
Telehealth cardiac rehabilitation
Participants will participate in 12-week in-person cardiac rehabilitation as delivered at the site where they are enrolled. The typical course is 36 sessions of group exercise, health education, and counseling over 12 weeks.
Participants will participate in 12-week telehealth cardiac rehabilitation. The program will follow the same core components as in-person cardiac rehabilitation, but in-person supervised exercise will not be required. The core element of telehealth cardiac rehabilitation is 12 weekly individual telehealth sessions between the patient and cardiac rehabilitation provider.